Core Diagnostics

Executive Summary

Core Diagnostics is a high-end clinical laboratory in India, founded in 2020, offering a broad portfolio of molecular, histopathology, cytology, flow cytometry, and genetic tests. Leveraging platforms such as NGS, ddPCR, PCR, IHC, and AI-driven data analytics, the company specializes in oncology, hereditary diseases, reproductive health, and cardiovascular disorders. Its focus on early detection and personalized treatment decisions positions it as a key player in India's growing precision diagnostics market. With 200-500 employees and a commercial-stage operation, Core Diagnostics has established itself as a reliable provider of multi-pathologist-reviewed diagnostic reports. The company's comprehensive test menu and advanced technology infrastructure enable it to serve a wide range of clinical needs, from routine diagnostics to complex genetic profiling.

Upcoming Catalysts (preview)

• Q3 2026Launch of Comprehensive Liquid Biopsy Panel for Solid Tumors70% success
• Q4 2026Partnership with Global Pharma for Companion Diagnostics50% success
• Q2 2026NABL/CAP Accreditation Expansion80% success